BDBM291354 2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine::US9580442, Example A::US9938290, A

SMILES C1CN(CCO1)c1nc(nc2c3cccnc3sc12)-c1cccc2[nH]ccc12

InChI Key InChIKey=JPTHGOJMUTXDSM-UHFFFAOYSA-N

Data  8 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 291354   

TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  137nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  54nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  15nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  873nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  54nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  137nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  15nMAssay Description:Please see articleMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform(Homo sapiens (Human))
Karus Therapeutics

US Patent
LigandPNGBDBM291354(2-(1H-Indol-4-yl)-4-morpholin-4-yl-pyrido[3′...)
Affinity DataIC50:  873nMAssay Description:PI3K Isoform using biochemical assay.More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent